APA način citiranja

Munakata, W., Ando, K., Hatake, K., Fukuhara, N., Kinoshita, T., Fukuhara, S., . . . Tobinai, K. (2019). Phase I study of tirabrutinib (ONO‐4059/GS‐4059) in patients with relapsed or refractory B‐cell malignancies in Japan. Cancer Sci.

Čikaški stil citiranja

Munakata, Wataru, et al. "Phase I Study of Tirabrutinib (ONO‐4059/GS‐4059) in Patients With Relapsed or Refractory B‐cell Malignancies in Japan." Cancer Sci 2019.

MLA način citiranja

Munakata, Wataru, et al. "Phase I Study of Tirabrutinib (ONO‐4059/GS‐4059) in Patients With Relapsed or Refractory B‐cell Malignancies in Japan." Cancer Sci 2019.